TIGIT and colorectal carcinoma: Gur C et al. showed that a CRC-associated bacterium (Fusobacterium nucleatum) inhibits human NK cells via TIGIT, which can be blocked by anti-TIGIT antibody (102), suggesting that NK-cell responses in CRC can be suppressed by the gut microbiome in a TIGIT-mediated fashion.